Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ. READ MORE


Bendeka injection has been approved by the FDA for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma that has progressed during or within 6 months of treatment with rituximab or a rituximab-containing regimen.